cMyc Cancer Research Results

cMyc, cellular-MYC oncogene: Click to Expand ⟱
Source:
Type: oncogene
The MYC proto-oncogenes are among the most commonly activated proteins in human cancer. The oncogene c-myc, which is frequently over-expressed in cancer cells, is involved in the transactivation of most of the glycolytic enzymes including lactate dehydrogenase A (LDHA) and the glucose transporter GLUT1 [51,52]. Thus, c-myc activation is a likely candidate to promote the enhanced glucose uptake and lactate release in the proliferating cancer cell. The c-Myc oncogene is a ‘master regulator’ of both cellular growth and metabolism in transformed cells.
-C-myc is a common oncogene that enhances aerobic glycolysis in the cancer cells by transcriptionally activating GLUT1, HK2, PKM2 and LDH-A

Inhibitors (downregulate):
Curcumin
Resveratrol: downregulate c-Myc expression.
Epigallocatechin Gallate (EGCG)
Quercetin
Berberine: decrease c-Myc expression and repress its transcriptional activity.


Scientific Papers found: Click to Expand⟱
5271- 3BP,    The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside
- Review, Var, NA
selectivity↑, selectivity↑, ATP↓, Glycolysis↓, HK2↓, mt-OXPHOS↓, GAPDH↓, mtDam↑, GSH↓, ROS↑, ER Stress↑, TumAuto↑, LC3‑Ⅱ/LC3‑Ⅰ↑, p62↓, Akt↓, HDAC↓, TumCA↑, Bcl-2↓, cMyc↓, Casp3↑, Cyt‑c↑, Mcl-1↓, PARP↓, ChemoSen↑,
6396- ANE,  FEO,    Anethole Inhibits the Proliferation of Human Prostate Cancer Cells via Induction of Cell Cycle Arrest and Apoptosis
- in-vitro, Pca, PC3
TumCP↓, TumCG↓, TumCMig↓, CSCs↓, ROS↑, MPT↑, Casp3↑, Casp9↑, DNAdam↑, cl‑PARP↑, Bax:Bcl2↑, TumCCA↑, cycD1/CCND1↓, CDK4↓, cMyc↓, P21↑, p27/CDKN1B↑, NF-kB↓, eff↑,
2639- Api,    Plant flavone apigenin: An emerging anticancer agent
- Review, Var, NA
*antiOx↑, *Inflam↓, AntiCan↑, ChemoSen↑, BioEnh↑, chemoPv↑, IL6↓, STAT3↓, NF-kB↓, IL8↓, eff↝, Akt↓, PI3K↓, HER2/EBBR2↓, cycD1/CCND1↓, CycD3↓, p27/CDKN1B↑, FOXO3↑, STAT3↓, MMP2↓, MMP9↓, VEGF↓, Twist↓, MMP↓, ROS↑, NADPH↑, NRF2↓, SOD↓, COX2/PTGS2↓, p38↑, Telomerase↓, HDAC↓, HDAC1↓, HDAC3↓, Hif1a↓, angioG↓, uPA↓, Ca+2↑, Bax:Bcl2↑, Cyt‑c↑, Casp9↑, Casp12↑, Casp3↑, cl‑PARP↑, E-cadherin↑, β-catenin/ZEB1↓, cMyc↓, CDK4↓, CDK2↓, CDK6↓, IGF-1↓, CK2↓, CSCs↓, FAK↓, Gli↓, GLUT1↓,
2314- Api,    Apigenin Restrains Colon Cancer Cell Proliferation via Targeted Blocking of Pyruvate Kinase M2-Dependent Glycolysis
- in-vitro, Colon, HCT116 - in-vitro, Colon, HT29 - in-vitro, Colon, DLD1
Glycolysis↓, PKM2:PKM1↓, β-catenin/ZEB1↓, cMyc↓,
3391- ART/DHA,    Antitumor Activity of Artemisinin and Its Derivatives: From a Well-Known Antimalarial Agent to a Potential Anticancer Drug
- Review, Var, NA
TumCP↓, TumMeta↓, angioG↓, TumVol↓, BioAv↓, Half-Life↓, BioAv↑, eff↑, eff↓, ROS↑, selectivity↑, TumCCA↑, survivin↓, BAX↑, Casp3↓, Casp8↑, Casp9↑, CDC25↓, CycB/CCNB1↓, NF-kB↓, cycD1/CCND1↓, cycE/CCNE↓, E2Fs↓, P21↑, p27/CDKN1B↑, ADP:ATP↑, MDM2↓, VEGF↓, IL8↓, COX2/PTGS2↓, MMP9↓, ER Stress↓, cMyc↓, GRP78/BiP↑, DNAdam↑, AP-1↓, MMP2↓, PKCδ↓, Raf↓, ERK↓, JNK↓, PCNA↓, CDK2↓, CDK4↓, TOP2↓, uPA↓, MMP7↓, TIMP2↑, Cdc42↑, E-cadherin↑,
2320- ART/DHA,    Dihydroartemisinin Inhibits the Proliferation of Leukemia Cells K562 by Suppressing PKM2 and GLUT1 Mediated Aerobic Glycolysis
- in-vitro, AML, K562 - in-vitro, Liver, HepG2
Glycolysis↓, GlucoseCon↓, lactateProd↓, GLUT1↓, PKM2↓, ECAR↓, LDHA↓, cMyc↓, other↝,
5380- ART/DHA,    Artemisinin and Its Derivatives as Potential Anticancer Agents
- Review, Var, NA
TumCG↓, angioG↓, Ferroptosis↑, TumCP↑, TumAuto↑, CSCs↑, eff↑, YAP/TEAD↓, TumCCA↑, ROS↑, ChemoSen↑, N-cadherin↓, Vim↓, MMP9↓, eff↑, STAT3↓, CD133↓, CD44↓, Nanog↓, cMyc↓, OCT4↓, Akt↓, mTOR↓,
556- ART/DHA,    Artemisinins as a novel anti-cancer therapy: Targeting a global cancer pandemic through drug repurposing
- Review, Var, NA
IL6↓, IL1↓, TNF-α↓, TGF-β↓, NF-kB↓, MIP2↓, PGE2↓, NO↓, Hif1a↓, VEGFR2/KDR/Flk1↓, VEGF↓, MMP2↓, TIMP2↑, ITGB1↑, NCAM↑, p‑ATM↑, p‑ATR↑, p‑CHK1↑, p‑Chk2↑, Wnt/(β-catenin)↓, PI3K↓, Akt↓, ERK↓, cMyc↓, mTOR↓, survivin↓, cMET↓, EGFR↓, cycD1/CCND1↓, cycE1↓, CDK4/6↓, p16↑, p27/CDKN1B↑, Apoptosis↑, TumAuto↑, Ferroptosis↑, oncosis↑, TumCCA↑, ROS↑, DNAdam↑, RAD51↓, HR↓,
5415- ASA,    The Anti-Metastatic Role of Aspirin in Cancer: A Systematic Review
- Review, Var, NA
TumMeta↓, COX1↓, TXA2↓, AntiAg↑, EMT↓, TumCMig↓, TumCI↓, AMPK↑, cMyc↓, PGE2↓, Dose↑, RadioS↑, PD-L1↓, E-cadherin↑, EMT↓, Slug↓, Vim↓, Twist↓, MMP2↓, MMP9↓, other↑,
2388- Ash,    Withaferin A decreases glycolytic reprogramming in breast cancer
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MDA-MB-468 - in-vitro, BC, MCF7 - in-vitro, BC, MDA-MB-453
GlucoseCon↓, lactateProd↓, ATP↓, Glycolysis↓, GLUT1↓, HK2↓, PKM2↓, cMyc↓, Warburg↓, cMyc↓,
3162- Ash,    Molecular insights into cancer therapeutic effects of the dietary medicinal phytochemical withaferin A
- Review, Var, NA
lipid-P↓, SOD↑, GPx↑, P53↑, Bcl-2↑, E6↓, E7↓, pRB↑, CycB/CCNB1↑, CDC2↑, P21↑, PCNA↓, ALDH1A1↓, Vim↓, Glycolysis↓, cMyc↓, BAX↑, NF-kB↓, Casp3↑, CHOP/DDIT3↑, DR5↑, ERK↓, Wnt↓, β-catenin/ZEB1↓, Akt↓, HSP90↓,
3167- Ash,    Withaferin A Inhibits the Proteasome Activity in Mesothelioma In Vitro and In Vivo
- in-vitro, MM, H226
TumCP↓, cMyc↓, cFos↓, cJun↓, TIMP2↑, Vim↓, ROS↑, BAX↑, IKKα↑, Casp3↑, cl‑PARP↑,
4816- ASTX,    Potent carotenoid astaxanthin expands the anti-cancer activity of cisplatin in human prostate cancer cells
- in-vitro, Pca, NA
*antiOx↑, *Inflam↓, ChemoSen↑, E-cadherin↑, N-cadherin↓, VEGF↓, cMyc↓, PSA↓, cl‑Casp3↑, PARP1↑,
5250- Ba,    Exploring baicalein: A natural flavonoid for enhancing cancer prevention and treatment
- Review, Var, NA
Apoptosis↑, TumAuto↑, DNAdam↑, *antiOx↑, Inflam↓, PGE2↓, TumCCA↑, TumCMig↓, TumCI↓, angioG↓, selectivity↑, ChemoSen↑, HIF-1↓, cMyc↓, NF-kB↓, VEGF↓, P53↑, MMP2↓, CSCs↓, Bcl-xL↓, XIAP↓, survivin↓, tumCV↓, Casp3↑, Casp8↑, Bax:Bcl2↑, Akt↓, mTOR↓, PCNA↓, MMP↓, ROS↑, PARP↑, Casp9↑, BioAv↑, Synergy↑, P-gp/ABCB1↓, BioAv↑, selectivity↑,
2474- Ba,    Anticancer properties of baicalein: a review
- Review, Var, NA - in-vitro, Nor, BV2
ROS⇅, ROS↑, ER Stress↑, Ca+2↑, Apoptosis↑, eff↑, DR5↑, 12LOX↓, Cyt‑c↑, Casp7↑, Casp9↑, Casp3↑, cl‑PARP↑, TumCCA↑, cycE/CCNE↑, CDK4↓, cycD1/CCND1↓, VEGF↓, cMyc↓, Hif1a↓, NF-kB↓, BioEnh↑, BioEnh↑, P450↓, *Hif1a↓, *iNOS↓, *COX2/PTGS2↓, *VEGF↓, *ROS↓, *PI3K↓, *Akt↓,
2606- Ba,    Baicalein: A review of its anti-cancer effects and mechanisms in Hepatocellular Carcinoma
- Review, HCC, NA
ChemoSen↑, TumCP↓, TumCCA↑, TumCMig↓, TumCI↓, MMPs↓, MAPK↓, TGF-β↓, ZFX↓, p‑MEK↓, ERK↓, MMP2↓, MMP9↓, uPA↓, TIMP1↓, TIMP2↓, NF-kB↓, p65↓, p‑IKKα↓, Fas↑, Casp2↑, Casp3↑, Casp8↑, Casp9↑, Bcl-xL↓, BAX↑, ER Stress↑, Ca+2↑, JNK↑, P53↑, ROS↑, H2O2↑, cMyc↓, CD24↓, 12LOX↓,
2617- Ba,    Potential of baicalein in the prevention and treatment of cancer: A scientometric analyses based review
- Review, Var, NA
Ca+2↑, MMP2↓, MMP9↓, Vim↓, Snail↓, E-cadherin↑, Wnt↓, β-catenin/ZEB1↓, p‑Akt↓, p‑mTOR↓, NF-kB↓, i-ROS↑, Bcl-2↓, BAX↑, Cyt‑c↑, Casp3↑, Casp9↑, STAT3↓, IL6↓, MMP2↓, MMP9↓, NOTCH↓, PPARγ↓, p‑NRF2↓, HK2↓, LDHA↓, PDK1 / PDPK1↓, Glycolysis↓, PTEN↑, Akt↓, Hif1a↓, MMP↓, VEGF↓, VEGFR2/KDR/Flk1↓, TOP2↓, uPA↓, TIMP1↓, TIMP2↓, cMyc↓, TrxR↓, ASK1↑, Vim↓, ZO-1↑, E-cadherin↑, SOX2↓, OCT4↓, Shh↓, Smo↓, Gli1↓, N-cadherin↓, XIAP↓,
2615- Ba,    The Multifaceted Role of Baicalein in Cancer Management through Modulation of Cell Signalling Pathways
- Review, Var, NA
*AntiCan↓, *Inflam↓, TumCP↓, NF-kB↓, PPARγ↑, TumCCA↑, JAK2↓, STAT3↓, TumCMig↓, Glycolysis↓, MMP2↓, MMP9↓, selectivity↑, VEGF↓, Hif1a↓, cMyc↓, ChemoSen↑, ROS↑, p‑mTOR↓, PTEN↑,
2626- Ba,    Molecular targets and therapeutic potential of baicalein: a review
- Review, Var, NA - Review, AD, NA - Review, Stroke, NA
AntiCan↓, *neuroP↑, *cardioP↑, *hepatoP↑, *RenoP↑, TumCCA↑, CDK4↓, cycD1/CCND1↓, cycE/CCNE↑, BAX↑, Bcl-2↓, VEGF↓, Hif1a↓, cMyc↓, NF-kB↓, ROS↑, BNIP3↑, *neuroP↑, *cognitive↑, *NO↓, *iNOS↓, *COX2/PTGS2↓, *PGE2↓, *NRF2↑, *p‑AMPK↑, *Ferroptosis↓, *lipid-P↓, *ALAT↓, *AST↓, *Fas↓, *BAX↓, *Apoptosis↓,
5541- BBM,    Berbamine Suppresses the Growth of Gastric Cancer Cells by Inactivating the BRD4/c-MYC Signaling Pathway
- in-vitro, GC, SGC-7901 - in-vitro, GC, BGC-823
TumCP↓, TumCCA↑, Apoptosis↑, BRD4↓, selectivity↑, TumCG↓, cMyc↓,
5542- BBM,    Pharmacological profiling of a berbamine derivative for lymphoma treatment
- vitro+vivo, lymphoma, NA
CaMKII ↓, TumCG↓, cMyc↓, ROS↑, UPR↑, ER Stress↑, PERK↑, BioAv↑, toxicity↓,
2021- BBR,    Berberine: An Important Emphasis on Its Anticancer Effects through Modulation of Various Cell Signaling Pathways
- Review, Var, NA
*antiOx?, *Inflam↓, Apoptosis↑, TumCCA↑, BAX↑, Synergy↑, VEGF↓, PI3K↓, Akt↓, mTOR↓, Telomerase↓, β-catenin/ZEB1↓, Wnt↓, EGFR↓, AP-1↓, NF-kB↓, COX2/PTGS2↑, NRF2↓, RadioS↑, STAT3↓, ERK↓, AR↓, ROS↑, eff↑, selectivity↑, selectivity↑, BioAv↓, DNMT1↓, cMyc↓,
1299- BBR,    Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review
- Review, Var, NA
TumCCA↑, TP53↑, COX2/PTGS2↓, Bax:Bcl2↑, ROS↑, VEGFR2/KDR/Flk1↓, Akt↓, ERK↓, MMP2↓, MMP9↓, IL8↑, P21↑, p27/CDKN1B↑, E-cadherin↓, Fibronectin↓, cMyc↓,
2712- BBR,    Suppression of colon cancer growth by berberine mediated by the intestinal microbiota and the suppression of DNA methyltransferases (DNMTs)
- in-vitro, Colon, HT29 - in-vivo, NA, NA
TumCG↓, GutMicro↑, other↝, IL10↓, cMyc↓, DNMT1↓, DNMTs↓,
2706- BBR,    Berberine Inhibits Growth of Liver Cancer Cells by Suppressing Glutamine Uptake
- in-vitro, HCC, Hep3B - in-vitro, HCC, Bel-7402 - in-vivo, NA, NA
TumCP↓, glut↓, SLC12A5↓, cMyc↓, GLS↓,
5634- BCA,    Molecular Mechanisms of Biochanin A in AML Cells: Apoptosis Induction and Pathway-Specific Regulation in U937 and THP-1
- in-vitro, AML, U937 - in-vitro, AML, THP1
Apoptosis↑, Casp7↑, PARP1↑, Bcl-2↓, Myc↓, CHOP/DDIT3↑, P21↑, p62↑, TumCCA↑, TXNIP↑, ROS↑, *antiOx↑, *Inflam↓, *neuroP↑, AntiCan↑, TumCP↓, angioG↓, TumMeta↓, VEGF↓, MMPs↓, tumCV↓, DNAdam↑, CHOP/DDIT3↑, cMyc↓, BioAv↓, Half-Life↓, BioAv↑,
6513- BCP,    β-Caryophyllene oxide potentiates TNFα-induced apoptosis and inhibits invasion through down-modulation of NF-κB-regulated gene products
- in-vitro, Var, NA
Apoptosis↑, TumCG↓, TumMeta↓, STAT3↓, PI3K↓, Akt↓, mTOR↓, ChemoSen↑, IAP1↓, IAP2/BIRC3↓, Bcl-2↓, Bcl-xL↓, survivin↓, COX2/PTGS2↓, cycD1/CCND1↓, cMyc↓, TumCI↓, MMP9↓, ICAM-1↓, angioG↓, VEGF↓, NF-kB↓,
943- BetA,    Betulinic acid suppresses breast cancer aerobic glycolysis via caveolin-1/NF-κB/c-Myc pathway
- in-vitro, BC, MCF7 - in-vitro, BC, MDA-MB-231 - in-vivo, NA, NA
Glycolysis↓, lactateProd↓, GlucoseCon↓, ECAR↓, cMyc↓, LDHA↓, p‑PDK1 / PDPK1↓, PDK1 / PDPK1↓, Cav1↑, *Glycolysis↑, selectivity↑, OCR↓, OXPHOS↓,
2738- BetA,    Betulinic Acid Suppresses Breast Cancer Metastasis by Targeting GRP78-Mediated Glycolysis and ER Stress Apoptotic Pathway
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, BT549 - in-vivo, NA, NA
TumCI↓, TumCMig↓, Glycolysis↓, lactateProd↓, GRP78/BiP↑, ER Stress↑, PERK↑, p‑eIF2α↑, β-catenin/ZEB1↓, cMyc↓, ROS↑, angioG↓, Sp1/3/4↓, DNAdam↑, TOP1↓, TumMeta↓, MMP2↓, MMP9↓, N-cadherin↓, Vim↓, E-cadherin↑, EMT↓, LDHA↓, p‑PDK1 / PDPK1↓, PDK1 / PDPK1↓, ECAR↓, OCR↓, Hif1a↓, STAT3↓,
5721- BF,    Bufalin Suppresses Triple-Negative Breast Cancer Stem Cell Growth by Inhibiting the Wnt/β-Catenin Signaling Pathway
- in-vitro, BC, NA
CSCs↓, TumCCA↑, cMyc↓, cycD1/CCND1↓, CDK4↓, MMP↓, Casp↑, CD133↓, CD44↓, ALDH1A1↓, Nanog↓, OCT4↓, SOX2↓, Wnt↓, β-catenin/ZEB1↓, EGFR↓,
9185- BITC,  PEITC,  AITC,  ITCs,    Effects of Brassicaceae Isothiocyanates on Prostate Cancer
- Review, Pca, NA
antiOx↑, Inflam↓, Bacteria↓, chemoPv↑, TumCCA↑, Apoptosis↑, ChemoSen↑, TumCP↓, TumCI↓, TumMeta↓, DNMTs↓, HDAC↓, HDAC6↓, AR↓, selectivity↑, CDK1↓, CycB/CCNB1↓, P53↑, WEE1↑, CDC25↓, cMyc↓, cycD1/CCND1↓, cycE/CCNE↓, CDK4↓, CDK6↓, XIAP↓, survivin↓, Bcl-2↓, compIII↓, APAF1↑, ROS↑, OXPHOS↓, MMP↓, Ca+2↑, CXCR4↓, IL6↓, JAK2↓, STAT3↓, mTOR↓, Synergy↑, CSCs↓, uPAR↓, NF-kB↓, TGF-β↓, angioG↓,
3525- Bor,    Synthesis of DNA-Boron Cluster Composites and Assembly into Functional Nanoparticles with Dual, Anti-EGFR, and Anti-c-MYC Oncogene Silencing Activity
- in-vitro, PC, PANC1
EGFR↓, cMyc↓,
1422- Bos,    Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA family
- in-vitro, CRC, NA - in-vivo, NA, NA
5LO↓, TumCG↓, Let-7↑, miR-200b↑, NF-kB↓, cMyc↓, cycD1/CCND1↓, MMP9↓, CXCR4↓, VEGF↓, Bcl-xL↓, survivin↓, IAP1↓, XIAP↓, TumCG↓, CDK6↓, Vim↓, E-cadherin↑,
1426- Bos,  CUR,  Chemo,    Novel evidence for curcumin and boswellic acid induced chemoprevention through regulation of miR-34a and miR-27a in colorectal cancer
- in-vivo, CRC, NA - in-vitro, CRC, HCT116 - in-vitro, CRC, RKO - in-vitro, CRC, SW480 - in-vitro, RCC, SW-620 - in-vitro, RCC, HT-29 - in-vitro, CRC, Caco-2
miR-34a↑, miR-27a-3p↓, TumCG↓, BAX↑, Bcl-2↓, PARP1↓, TumCCA↑, Apoptosis↑, cMyc↓, CDK4↓, CDK6↓, cycD1/CCND1↓, ChemoSen↑, miR-34a↑, miR-27a-3p↓,
5695- BRU,    Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
- in-vitro, Lung, A549
NRF2↓, ChemoSen↑, Apoptosis↑, TumCP↓, TumCG↓, MRP1/ABCC1↓, GSH↓, cMyc↓,
5697- BRU,    Brusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in Head and Neck Squamous Cell Carcinoma
- in-vitro, HNSCC, NA
NRF2↓, STAT3↓, proCasp3↑, cl‑PARP↑, Bcl-2↓, Bcl-xL↓, survivin↓, Hif1a↓, cMyc↓, JNK↑, MAPK↑, tumCV↓, ROS∅,
1640- CA,  MET,    Caffeic Acid Targets AMPK Signaling and Regulates Tricarboxylic Acid Cycle Anaplerosis while Metformin Downregulates HIF-1α-Induced Glycolytic Enzymes in Human Cervical Squamous Cell Carcinoma Lines
- in-vitro, Cerv, SiHa
GLS↓, NADPH↓, ROS↑, TumCD↑, AMPK↑, Hif1a↓, GLUT1↓, GLUT3↓, HK2↓, PFK↓, PKM2↓, LDH↓, cMyc↓, BAX↓, cycD1/CCND1↓, PDH↓, ROS↑, Apoptosis↑, eff↑, ACLY↓, FASN↓, Bcl-2↓, Glycolysis↓,
6652- Cen,    AA-PMe, a novel asiatic acid derivative, induces apoptosis and suppresses proliferation, migration, and invasion of gastric cancer cells
- in-vitro, GC, SGC-7901 - in-vitro, GC, HGC27
TumCP↓, selectivity↑, TumCCA↑, cycD1/CCND1↓, CDK4↓, Apoptosis↑, Bcl-2↓, BAX↑, cMyc↓, Casp3↑, TumCMig↓, TumCI↓, MMP2↓, MMP9↓, tumCV↓,
6002- CGA,    Chlorogenic Acid: A Systematic Review on the Biological Functions, Mechanistic Actions, and Therapeutic Potentials
- Review, Var, NA - Review, Diabetic, NA - Review, AD, NA - Review, Park, NA - Review, Stroke, NA
*neuroP↑, *Inflam↓, *antiOx↑, *cardioP↑, *NRF2↑, *AMPK↑, *SOD↑, *Catalase↑, *GSH↑, *GPx↑, *ROS↓, *TNF-α↓, *IL6↓, *NF-kB↓, *COX2/PTGS2↓, *glucose↓, *TRPC1↓, *Ca+2↓, *HO-1↑, *NF-kB↓, *PPARα↝, *Hif1a↓, *JNK↓, *BP↓, *AntiDiabetic↑, *hepatoP↑, *TLR4↓, *NRF2↑, *Casp↓, *neuroP↑, *Aβ↓, *LDH↓, *MDA↓, *memory↑, *AChE↓, *Stroke↓, EMT↝, N-cadherin↓, E-cadherin↑, TumCCA↑, ROS↑, p‑P53↑, HO-1↑, NRF2↑, ChemoSen↑, mtDam↑, Casp3↑, Casp9↑, PARP↑, Bax:Bcl2↑, TumCG↓, cycD1/CCND1↓, cMyc↓, CDK2↓, mitResp↓, Glycolysis↓, Hif1a↓, PCNA↓, p‑GSK‐3β↓, VEGF↓, PI3K↓, Akt↓, mTOR↓, OS↑,
6135- CHr,    Chrysin as a Multifunctional Therapeutic Flavonoid: Emerging Insights in Pathogenesis Management: A Narrative Review
- Review, Var, NA - Review, AD, NA
Inflam↓, angioG↓, Apoptosis↑, TumAuto↑, TumCCA↑, BioAv↓, Half-Life↓, BioAv↓, *ROS↓, *hepatoP↑, *RenoP↑, TET1↑, MMP9↓, cMyc↓, Ki-67↓, CBR1↓, ROS↑, ChemoSen↑, Bax:Bcl2↑, PUMA↑, NOTCH1↑, *AntiDiabetic↑, *neuroP↑, *GABA↑, *DNAdam↓, *BDNF↑, *memory↑, *AGEs↓, *Aβ↓, *cardioP↑, *AntiArt↑, Synergy↑, Synergy↑, *Synergy↑, RadioS↑, Synergy↑, ChemoSen↑, eff↑,
2781- CHr,  PBG,    Chrysin a promising anticancer agent: recent perspectives
- Review, Var, NA
PI3K↓, Akt↓, mTOR↓, MMP9↑, uPA↓, VEGF↓, AR↓, Casp↑, TumMeta↓, TumCCA↑, angioG↓, BioAv↓, *hepatoP↑, *neuroP↑, *SOD↑, *GPx↑, *ROS↓, *Inflam↓, *Catalase↑, *MDA↓, ROS↓, BBB↑, Half-Life↓, BioAv↑, ROS↑, Synergy↑, ROS↑, ROS↑, lipid-P↑, ER Stress↑, NOTCH1↑, NRF2↓, p‑FAK↓, Rho↓, PCNA↓, COX2/PTGS2↓, NF-kB↓, PDK1 / PDPK1↓, PDK3↑, GLUT1↓, Glycolysis↓, mt-ATP↓, Ki-67↓, cMyc↓, ROCK1↓, TOP1↓, TNF-α↓, IL1β↓, CycB/CCNB1↓, CDK2↓, EMT↓, STAT3↓, PD-L1↓, IL2↑,
6308- Cro,    Dietary Crocin is Protective in Pancreatic Cancer while Reducing Radiation-Induced Hepatic Oxidative Damage
- vitro+vivo, PC, Bxpc-3
Bcl-2↓, Apoptosis↑, Cyt‑c↑, TumCG↓, radioP↑, TumCCA↑, TumCP↓, DNAdam↑, TBARS↓, P53↑, p38↑, CDK2↓, cMyc↓, *MDA↓, GSH↑,
6200- Cuc,  GEM,    Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer
- in-vivo, PC, NA
Synergy↑, TumCG↓, Bcl-xL↓, Bcl-2↓, cMyc↓, Casp↑, STAT3↓, JAK2↓,
4826- CUR,    The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management
- Review, Var, NA
*antiOx↑, *Inflam↑, *ROS↓, Apoptosis↑, TumCP↓, BioAv↓, Half-Life↓, eff↑, TumCCA↑, BAX↑, Bak↑, PUMA↑, BIM↑, NOXA↑, TRAIL↑, Bcl-2↓, Bcl-xL↓, survivin↓, XIAP↓, cMyc↓, Casp↑, NF-kB↓, STAT3↓, AP-1↓, angioG↓, TumMeta↑, VEGF↓, MMPs↓, DNMTs↓, HDAC↓, ROS↑,
4709- CUR,    Curcumin Regulates Cancer Progression: Focus on ncRNAs and Molecular Signaling Pathways
- Review, Var, NA
miR-21↓, TumCP↓, TumCMig↓, TumCI↓, Apoptosis↑, miR-99↑, JAK↓, STAT↓, cycD1/CCND1↓, P21↑, ChemoSen↑, miR-192-5p↑, cMyc↓, Wnt↓, β-catenin/ZEB1↓, miR-130a↓,
470- CUR,    Regulation of carcinogenesis and modulation through Wnt/β-catenin signaling by curcumin in an ovarian cancer cell line
- in-vitro, Ovarian, SKOV3
Wnt/(β-catenin)↓, EMT↓, DNMT3A↓, cycD1/CCND1↓, cMyc↓, Fibronectin↓, Vim↓, E-cadherin↑, SFRP5↑,
406- CUR,    Effect of curcumin on normal and tumor cells: Role of glutathione and bcl-2
- in-vitro, BC, MCF7 - in-vitro, Hepat, HepG2
GSH↓, Apoptosis↑, Bcl-2↓, cMyc↓,
437- CUR,    Anti-cancer activity of amorphous curcumin preparation in patient-derived colorectal cancer organoids
- vitro+vivo, CRC, TCO1 - vitro+vivo, CRC, TCO2
cycD1/CCND1↓, cMyc↓, p‑ERK↓, CD44↓, CD133↓, LGR5↓, TumCCA↑, TumVol↓, CSCs↓,
126- CUR,    Modulation of miR-34a in curcumin-induced antiproliferation of prostate cancer cells
- in-vitro, Pca, 22Rv1 - in-vitro, Pca, PC3 - in-vitro, Pca, DU145
miR-34a↑, β-catenin/ZEB1↓, cMyc↓, P21↑, cycD1/CCND1↓, PCNA↓, TumCG↓,
12- CUR,    Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells
- in-vitro, MB, DAOY
HH↓, Shh↓, Gli1↓, PTCH1↓, cMyc↓, n-MYC↓, cycD1/CCND1↓, Bcl-2↓, NF-kB↓, Akt↓, β-catenin/ZEB1↓, survivin↓, Apoptosis↑, ChemoSen↑, RadioS↑, Synergy↑,

Showing Research Papers: 1 to 50 of 160
Page 1 of 4 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 160

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 2,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 1,   antiOx↑, 5,   Catalase↓, 1,   Catalase↑, 1,   Fenton↑, 1,   GPx↓, 1,   GPx↑, 4,   GSH↓, 11,   GSH↑, 5,   GSR↑, 1,   GSTs↓, 1,   GSTs↑, 1,   H2O2↑, 1,   HO-1↓, 2,   HO-1↑, 7,   HO-2↓, 1,   Iron↓, 1,   Iron↑, 1,   lipid-P↓, 2,   lipid-P↑, 3,   MDA↓, 1,   MDA↑, 1,   MPO↓, 1,   NQO1↑, 2,   Nrf1↓, 1,   NRF2↓, 7,   NRF2↑, 8,   p‑NRF2↓, 1,   Prx4↑, 1,   PYCR1↓, 1,   ROS↓, 12,   ROS↑, 70,   ROS⇅, 3,   ROS↝, 2,   ROS∅, 1,   i-ROS↑, 2,   mt-ROS↑, 1,   SOD↓, 5,   SOD↑, 5,   SOD1↑, 1,   SOD2↑, 1,   TBARS↓, 1,   Trx↓, 1,   TrxR↓, 3,   TrxR1↓, 2,   xCT/SLC7A11↓, 2,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 1,   BCR↓, 1,   Bfl-1↓, 1,   CDC16↓, 1,   CDC2↑, 1,   CDC25↓, 4,   compIII↓, 1,   EGF↓, 2,   mitResp↓, 2,   mtDam↑, 4,   OCR↓, 2,   OXPHOS↓, 2,   mt-OXPHOS↓, 1,   PDH↓, 2,   PDH↑, 1,   PGC-1α↓, 1,   SIRT3↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 2,   5LO↓, 3,   ACC↓, 1,   ACC↑, 1,   ACLY↓, 1,   ALAT↓, 2,   AMPK↑, 8,   ATP↓, 6,   mt-ATP↓, 1,   CAIX/CA9↓, 1,   ECAR↓, 3,   ECAR↝, 1,   FASN↓, 2,   G6PD↓, 1,   GAPDH↓, 1,   GLS↓, 3,   GlucoseCon↓, 11,   GlucoseCon↑, 1,   glut↓, 1,   GlutaM↓, 1,   Glycolysis↓, 30,   Glycolysis↑, 1,   GSK‐3β↓, 8,   GSK‐3β↑, 2,   p‑GSK‐3β↓, 4,   HK2↓, 18,   HK2↑, 1,   lactateProd↓, 12,   lactateProd↑, 1,   LDHA↓, 12,   LDHA↑, 1,   NADPH↓, 1,   NADPH↑, 1,   PDK1 / PDPK1?, 2,   PDK1 / PDPK1↓, 4,   p‑PDK1 / PDPK1↓, 2,   PDK3↑, 1,   PFK↓, 2,   PFK1↓, 1,   PKM2↓, 10,   p‑PKM2↓, 1,   PKM2:PKM1↓, 2,   PPP↓, 2,   Pyruv↑, 1,   SIRT1↓, 3,   SIRT1↑, 2,   SIRT2↓, 2,   TCA↓, 1,   TCA↑, 1,   Warburg↓, 5,  

Cell Death(tgid=5) ⓘ

AIF↑, 3,   APAF1↑, 2,   Apoptosis?, 1,   Apoptosis↓, 3,   Apoptosis↑, 64,   ASK1↑, 1,   BAD↑, 2,   Bak↑, 2,   BAX↓, 5,   BAX↑, 32,   Bax:Bcl2↑, 15,   Bcl-2↓, 50,   Bcl-2↑, 3,   Bcl-xL↓, 21,   BID↑, 1,   BIM↓, 1,   BIM↑, 2,   BNIP3↑, 1,   BOK↑, 1,   Casp↑, 7,   Casp10↑, 1,   Casp12↑, 1,   cl‑Casp12↑, 1,   Casp2↑, 1,   Casp3↓, 4,   Casp3↑, 45,   cl‑Casp3↑, 6,   proCasp3↓, 1,   proCasp3↑, 1,   Casp7↑, 12,   cl‑Casp7↑, 1,   Casp8↑, 10,   cl‑Casp8↑, 1,   Casp9↑, 29,   cl‑Casp9↑, 2,   cFLIP↓, 4,   Cyt‑c↑, 20,   Diablo↑, 3,   DIDO1/DIO-1↑, 1,   DR5↓, 1,   DR5↑, 9,   FADD↑, 1,   Fas↑, 5,   FasL↑, 1,   Ferroptosis↑, 3,   GSDME-N↑, 1,   IAP1↓, 8,   IAP2/BIRC3↓, 6,   ICD↑, 1,   iNOS↓, 4,   Mcl-1?, 1,   Mcl-1↓, 8,   Mcl-1↑, 1,   MDM2↓, 6,   NAIP↓, 1,   necrosis↑, 1,   NOXA↑, 3,   oncosis↑, 1,   p38↑, 8,   p‑p38↓, 1,   p‑p38↑, 1,   PUMA↑, 5,   Pyro↑, 1,   survivin↓, 42,   TNFR 1↑, 1,   TRAIL↑, 1,   TRAILR↑, 1,   TumCD↑, 3,   XIAP?, 1,   XIAP↓, 18,   YAP/TEAD↓, 3,   β-TRCP↑, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 46,   Akt↑, 3,   p‑Akt↓, 9,   p‑Akt↑, 1,   AKT1↓, 3,   Akt2↓, 1,   BRAF↓, 1,   CaMKII ↓, 1,   CDC7↓, 1,   CK2↓, 2,   cMET↓, 3,   cSrc↓, 1,   EF-1α↓, 1,   EGFR↓, 17,   ERK↓, 18,   ERK↑, 3,   p‑ERK↓, 6,   FGFR1↓, 4,   FGFR2↓, 1,   HER2/EBBR2↓, 5,   p‑HER2/EBBR2↓, 1,   IKKα↓, 6,   IKKα↑, 1,   p‑IKKα↓, 1,   JAK↓, 4,   JAK1↓, 4,   JAK2↓, 9,   JNK↓, 1,   JNK↑, 6,   p‑JNK↓, 1,   MAPK↓, 9,   MAPK↑, 2,   p‑MAPK↑, 1,   MEK↓, 1,   p‑MEK↓, 2,   mTOR↓, 29,   p‑mTOR↓, 6,   mTORC2↓, 1,   P90RSK↓, 1,   PI3K↓, 34,   PI3K↑, 1,   PKA↓, 1,   PKCδ↓, 5,   PTEN↑, 14,   Raf↓, 3,   c-Raf↓, 1,   RAS↓, 5,   Sp1/3/4↓, 6,   Sp1/3/4↑, 1,   STAT↓, 2,   STAT3↓, 46,   p‑STAT3↓, 9,   STAT6↓, 2,   STK11/LKB1↑, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF2↓, 1,   ATF4↑, 2,   ATF4↝, 1,   BRD4↓, 1,   CBP↑, 1,   cJun↓, 3,   cJun↑, 2,   cMyc↓, 162,   DNMT1↓, 4,   DNMT3A↓, 1,   DNMT3B↓, 1,   DNMTs↓, 4,   EZH2↓, 1,   FOXM1↓, 2,   FOXO3↑, 2,   p‑FOXO3↓, 1,   H3↑, 1,   ac‑H3↑, 2,   H4↑, 1,   ac‑H4↑, 2,   HATs↑, 2,   HDAC↓, 11,   HDAC1↓, 2,   HDAC2↓, 3,   HDAC3↓, 4,   HDAC6↓, 1,   HES1↓, 1,   IRF1↑, 1,   KLF4↓, 1,   miR-122-5p↑, 1,   miR-126↑, 1,   miR-130a↓, 1,   miR-134↑, 1,   miR-192-5p↑, 1,   miR-195↑, 1,   miR-199↑, 1,   miR-200b↑, 1,   miR-206↑, 1,   miR-21↓, 2,   miR-21↑, 2,   miR-221↑, 1,   miR-222↑, 1,   miR-27a-3p↓, 2,   miR-326-5p↑, 1,   miR-339-5p↝, 1,   miR-34a↑, 5,   miR-34b-5p↑, 2,   miR-384↑, 1,   miR-99↑, 1,   Myc↓, 3,   n-MYC↓, 1,   OCT4↓, 10,   other↓, 1,   other↑, 2,   other↝, 2,   SOX2↓, 8,   SOX4↓, 1,   SOX4↑, 1,   tumCV?, 1,   tumCV↓, 15,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↑, 11,   cl‑CHOP/DDIT3↑, 1,   eIF2α↑, 1,   p‑eIF2α↑, 2,   ER Stress↓, 1,   ER Stress↑, 13,   GRP78/BiP↑, 6,   HSP27↓, 2,   HSP70/HSPA5↓, 3,   HSP90↓, 3,   PERK↑, 3,   UPR↑, 1,   XBP-1↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG5↑, 1,   ATG7↑, 1,   Beclin-1/ATG6↓, 1,   Beclin-1/ATG6↑, 4,   LC3‑Ⅱ/LC3‑Ⅰ↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3B-II↑, 1,   LC3II↓, 1,   LC3II↑, 4,   p62↓, 1,   p62↑, 2,   TumAuto↑, 10,  

DNA Damage & Repair(tgid=10) ⓘ

p‑ATM↑, 1,   p‑ATR↑, 1,   BRCA1↑, 1,   CUL4B↑, 1,   DFF45↑, 1,   DNAdam↓, 2,   DNAdam↑, 18,   mt-DNAdam↑, 1,   HR↓, 1,   hTERT/TERT↓, 4,   MSH2↑, 1,   p16↑, 2,   P53↓, 1,   P53↑, 39,   p‑P53↓, 1,   p‑P53↑, 3,   PARP↓, 2,   PARP↑, 7,   cl‑PARP↑, 25,   proPARP↓, 1,   PARP1↓, 1,   PARP1↑, 4,   cl‑PARP1↑, 1,   PCNA↓, 19,   RAD51↓, 1,   SIRT6↑, 1,   Telomerase↓, 6,   TOP1↓, 2,   TOP2↓, 5,   TP53↑, 2,   γH2AX↓, 1,   γH2AX↑, 2,   p‑γH2AX↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

BRD4↓, 1,   CDK1↓, 8,   CDK2↓, 15,   CDK2↑, 1,   CDK4↓, 26,   CDK4/6↓, 2,   CDK6↓, 12,   CDK8↓, 3,   CHK1↓, 1,   p‑CHK1↑, 1,   Chk2↓, 1,   p‑Chk2↑, 1,   cycA1/CCNA1↓, 3,   CycB/CCNB1↓, 12,   CycB/CCNB1↑, 1,   cycD1/CCND1↓, 66,   CycD3↓, 1,   cycE/CCNE↓, 9,   cycE/CCNE↑, 2,   cycE1↓, 1,   cycF↓, 1,   E2Fs↓, 3,   Ki-67↓, 9,   mitA↑, 1,   P21?, 1,   P21↓, 2,   P21↑, 27,   p27/CDKN1B↓, 1,   p27/CDKN1B↑, 13,   pRB↑, 1,   p‑pRB↓, 2,   RB1↓, 1,   RB1↑, 2,   p‑RB1↓, 3,   TumCCA↓, 1,   TumCCA↑, 65,   WEE1↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ALDH↓, 3,   ALDH1A1↓, 5,   Axin2↑, 1,   CD133↓, 8,   CD133↑, 1,   CD24↓, 1,   cFos↓, 4,   CSCs↓, 23,   CSCs↑, 1,   EP300↑, 1,   FGF↓, 2,   Gli↓, 2,   Gli1↓, 4,   HH↓, 2,   IGF-1↓, 2,   IGFBP3↑, 1,   Ki-67↓, 9,   Let-7↑, 2,   LGR5↓, 1,   LRP6↓, 1,   mTORC1↓, 5,   Nanog↓, 12,   Nestin↓, 2,   NF2↑, 1,   NOTCH↓, 8,   NOTCH↑, 1,   NOTCH1↓, 3,   NOTCH1↑, 2,   NOTCH3↓, 1,   PTCH1↓, 3,   PTCH2↓, 1,   SFRP5↑, 1,   Shh↓, 8,   Smo↓, 3,   STAT1↓, 1,   TOPflash↓, 1,   TumCG↓, 39,   TumCP↓, 53,   TumCP↑, 2,   tyrosinase↓, 1,   Wnt↓, 21,   Wnt/(β-catenin)↓, 5,   ZFX↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↓, 1,   AntiAg↑, 2,   AP-1↓, 4,   APC↑, 1,   Ca+2↑, 9,   Ca+2↝, 2,   Cav1↑, 2,   Cdc42↑, 1,   COL1↓, 1,   COL3A1↓, 1,   E-cadherin↓, 7,   E-cadherin↑, 20,   EMT↓, 30,   EMT↝, 1,   FAK↓, 2,   p‑FAK↓, 2,   Fibronectin↓, 2,   GLI2↓, 2,   ITGB1↑, 1,   KRAS↓, 1,   LEF1↓, 2,   MALAT1↓, 1,   MET↓, 1,   MET↑, 1,   MMP13↓, 1,   MMP16↓, 1,   MMP2↓, 30,   MMP3↓, 2,   MMP7↓, 6,   MMP9↓, 40,   MMP9↑, 1,   MMPs↓, 15,   N-cadherin↓, 13,   NCAM↑, 1,   PDGF↓, 3,   Rho↓, 1,   ROCK1↓, 1,   Slug↓, 8,   Smad1↓, 1,   SMAD3↓, 1,   Snail↓, 14,   TET1↑, 1,   TGF-β↓, 9,   TIMP1↓, 2,   TIMP1↑, 1,   TIMP2↓, 2,   TIMP2↑, 3,   TSC1↑, 1,   TSP-1↑, 3,   TumCA↑, 1,   TumCI↓, 27,   TumCMig↓, 26,   TumCMig↑, 1,   TumMeta↓, 22,   TumMeta↑, 2,   Twist↓, 11,   TXNIP↑, 1,   uPA↓, 9,   uPAR↓, 2,   UroPA↓, 1,   Vim↓, 22,   Zeb1↓, 6,   α-SMA↓, 1,   β-catenin/ZEB1↓, 41,   β-catenin/ZEB1↑, 1,   p‑β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 32,   angioG↑, 1,   CD31/PECAM-1↓, 1,   Endoglin↑, 1,   HIF-1↓, 1,   Hif1a↓, 26,   Hif1a↑, 1,   LOX1↓, 1,   NO↓, 3,   TXA2↓, 1,   VCAM-1↓, 1,   VEGF↓, 48,   VEGFR1↓, 1,   VEGFR2/KDR/Flk1↓, 9,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   BBB∅, 1,   CellMemb↑, 1,   CLDN2↓, 1,   GLUT1↓, 10,   GLUT1↑, 1,   GLUT3↓, 1,   KCNH2/hERG↓, 1,   MMP↓, 20,   MPT↑, 1,   NHE1↓, 1,   SLC12A5↓, 1,   TRPV1↝, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD44↓, 10,   cDC2↓, 1,   COX1↓, 3,   COX2/PTGS2↓, 33,   COX2/PTGS2↑, 1,   CXCL12↓, 1,   CXCR4↓, 12,   DR4↑, 1,   ICAM-1↓, 5,   IFN-γ↓, 2,   IFN-γ↑, 1,   IL1↓, 3,   IL1↑, 1,   IL10↓, 6,   IL12↓, 2,   IL1β↓, 7,   IL2↓, 1,   IL2↑, 3,   IL4↑, 1,   IL6↓, 23,   IL7↓, 1,   IL8↓, 5,   IL8↑, 1,   Inflam↓, 12,   MCP1/CCL2↓, 1,   MDSCs↓, 1,   MIP2↓, 1,   NF-kB↓, 56,   NF-kB↑, 1,   p‑NF-kB↓, 1,   p‑NF-kB↑, 1,   p50↓, 1,   p65↓, 4,   p‑p65↓, 1,   ac‑p65↓, 1,   ac‑p65↑, 1,   PD-L1↓, 3,   PGE2↓, 7,   PSA↓, 5,   RAGE↓, 1,   RANTES↓, 1,   SOCS1↑, 1,   TCF↓, 5,   TCF7/TCF1↓, 1,   TLR4↓, 1,   TNF-α↓, 13,   TNF-α↑, 1,   TRAF1↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

pH↓, 2,  

Protein Aggregation(tgid=19) ⓘ

XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AR↓, 8,   ER(estro)↓, 1,   PPARγ↓, 2,   PPARγ↑, 2,   SRC3↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 16,   BioAv↑, 12,   BioAv↝, 2,   BioEnh?, 1,   BioEnh↑, 4,   CBR1↓, 1,   ChemoSen↓, 1,   ChemoSen↑, 42,   ChemoSen⇅, 1,   CompStab↓, 1,   CompStab↝, 1,   CYP1A1↓, 1,   Dose?, 1,   Dose↑, 3,   Dose↝, 6,   Dose∅, 1,   eff↓, 11,   eff↑, 25,   eff↝, 2,   GSTA1↑, 1,   Half-Life↓, 8,   Half-Life↑, 1,   Half-Life↝, 3,   MDR1↓, 4,   MRP1/ABCC1↓, 2,   P-gp/ABCB1↓, 6,   P450↓, 3,   RadioS↑, 16,   selectivity↑, 22,   Synergy↑, 36,  

Clinical Biomarkers(tgid=22) ⓘ

AFP?, 1,   ALAT↓, 2,   ALP↓, 1,   AR↓, 8,   AST↓, 2,   BRAF↓, 1,   BRCA1↑, 1,   CRP↓, 2,   E6↓, 1,   E7↓, 1,   EGFR↓, 17,   EZH2↓, 1,   FOXM1↓, 2,   HER2/EBBR2↓, 5,   p‑HER2/EBBR2↓, 1,   hTERT/TERT↓, 4,   IL6↓, 23,   KRAS↓, 1,   LDH↓, 3,   LDH↑, 1,   Myc↓, 3,   PD-L1↓, 3,   PSA↓, 5,   RAGE↓, 1,   TP53↑, 2,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↓, 1,   AntiCan↑, 12,   cachexia↓, 1,   cardioP↑, 4,   chemoP↑, 4,   chemoPv↑, 6,   ChemoSideEff↓, 2,   hepatoP↑, 3,   neuroP↑, 3,   Obesity↓, 1,   OS↑, 5,   radioP↑, 2,   RenoP↑, 2,   Risk↓, 1,   Strength↑, 1,   TGFβR1↑, 1,   toxicity↓, 5,   toxicity∅, 1,   TumVol↓, 5,   TumW↓, 4,   Weight∅, 1,  

Infection & Microbiome(tgid=24) ⓘ

Bacteria↓, 1,   GutMicro↑, 1,  
Total Targets: 667

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx?, 1,   antiOx↑, 16,   Catalase↑, 7,   GPx↑, 4,   GSH↑, 10,   GSTs↑, 1,   HO-1?, 1,   HO-1↑, 6,   lipid-P↓, 6,   MDA↓, 9,   Nrf1↑, 1,   NRF2↓, 1,   NRF2↑, 9,   ROS↓, 18,   ROS↑, 1,   SOD↑, 9,   Trx1↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

SIRT3↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↝, 1,   ALAT↓, 4,   AMPK↑, 4,   p‑AMPK↑, 1,   ATP↑, 1,   FASN↓, 1,   glucose↓, 2,   GlucoseCon↑, 1,   Glycolysis↑, 1,   GSK‐3β↓, 2,   LDHA↑, 1,   NAD↑, 1,   SIRT1↑, 3,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 1,   BAX↓, 1,   Bcl-2↑, 3,   Casp↓, 1,   Casp3↓, 3,   Casp9↓, 2,   Cyt‑c↓, 1,   Fas↓, 1,   Ferroptosis↓, 1,   GSDMD↓, 1,   iNOS↓, 3,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 1,   JNK↓, 1,   MAPK↓, 1,   PI3K↓, 1,   STAT3↓, 1,   STAT3↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

HDAC2↓, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

ER Stress↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 2,   p16↓, 1,   P53↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

P21↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 2,   AP-1↓, 1,   Ca+2↓, 1,   LRP1↑, 1,   MMP13↓, 1,   MMP9↓, 1,   MUC1↑, 1,   TGF-β↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,   angioG↑, 2,   eNOS↑, 1,   Hif1a↓, 2,   NO↓, 2,   NO↑, 1,   VEGF↓, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   GLUT2↑, 1,   GLUT3↑, 1,   GLUT4↑, 1,   IBI↑, 1,   TRPC1↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

COX2/PTGS2↓, 9,   IL10↓, 1,   IL10↑, 2,   IL17↓, 1,   IL1β↓, 5,   IL4↓, 1,   IL5↓, 1,   IL6↓, 5,   IL8↓, 1,   Imm↑, 1,   Inflam↓, 22,   Inflam↑, 2,   MCP1/CCL2↓, 1,   NeuroI↓, 1,   NF-kB↓, 6,   PGE2↓, 3,   RAGE↓, 1,   TLR4↓, 1,   TNF-α↓, 8,   β-HEX↓, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 1,   AChE↓, 3,   BDNF↑, 1,   GABA↑, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 1,   Aβ↓, 4,   tau↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

PPARα↝, 1,   PPARγ↑, 2,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 10,   BioAv↑, 4,   BioAv↝, 3,   BioEnh↑, 1,   ChemoSen↑, 1,   Dose↝, 1,   eff↑, 1,   GSTA1↑, 1,   Half-Life↑, 1,   Half-Life↝, 1,   P450↓, 1,   Synergy↑, 7,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 4,   ALP↓, 1,   AST↓, 4,   BMD↑, 2,   BP↓, 2,   CRP↓, 2,   IL6↓, 5,   LDH↓, 2,   NOS2↓, 1,   RAGE↓, 1,  

Functional Outcomes(tgid=23) ⓘ

antiAll↑, 4,   AntiArt↑, 2,   AntiCan↓, 1,   AntiCan↑, 2,   AntiDiabetic↑, 4,   cardioP↑, 10,   cognitive↑, 3,   diuretic↑, 1,   hepatoP↑, 14,   memory↑, 5,   motorD↑, 1,   neuroP↑, 20,   Obesity↓, 2,   Pain↓, 1,   RenoP↑, 3,   Stroke↓, 2,   toxicity↓, 3,   toxicity∅, 1,   Wound Healing↑, 2,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 2,   AntiFungal↑, 1,   AntiP↑, 1,   AntiViral↑, 3,   Bacteria↓, 1,   Bacteria↑, 1,   GutMicro↑, 1,  
Total Targets: 154

Scientific Paper Hit Count for: cMyc, cellular-MYC oncogene
12 Curcumin
10 Quercetin
8 Thymoquinone
7 Resveratrol
6 Baicalein
4 Artemisinin
4 Berberine
4 Luteolin
4 Lycopene
4 Piperlongumine
4 Silymarin (Milk Thistle) silibinin
3 Ashwagandha(Withaferin A)
3 Phenethyl isothiocyanate
3 EGCG (Epigallocatechin Gallate)
3 Sulforaphane (mainly Broccoli)
3 lambertianic acid
2 Apigenin (mainly Parsley)
2 Aspirin
2 Berbamine
2 Betulinic acid
2 Isothiocyanates
2 Boswellia (frankincense)
2 brusatol
2 Chrysin
2 Ellagic acid
2 Emodin
2 Ferulic acid
2 Gambogic Acid
2 mebendazole
2 Magnetic Fields
2 Niclosamide (Niclocide)
2 Nimbolide
2 Piperine
2 Pterostilbene
2 Ursolic acid
2 Vitamin K2
1 3-bromopyruvate
1 Anethole/trans-Anethole
1 Fennel Oil/Foeniculum vulgare
1 Astaxanthin
1 Biochanin A
1 Beta-Caryophyllene
1 Bufalin/Huachansu
1 Benzyl isothiocyanate
1 Allyl isothiocyanate
1 Boron
1 Chemotherapy
1 Caffeic acid
1 Metformin
1 Centella asiatica / Gotu kola → asiaticoside
1 Chlorogenic acid
1 Propolis -bee glue
1 Crocetin
1 Cucurbitacin
1 Gemcitabine (Gemzar)
1 Cynaropicrin
1 Deguelin
1 Diclofenac
1 Docosahexaenoic Acid
1 Genistein (soy isoflavone)
1 Evodiamine
1 Fisetin
1 flavonoids
1 Galloflavin
1 Geraniol
1 Ginger/6-Shogaol/Gingerol
1 Grapeseed extract
1 Honokiol
1 Indole-3-carbinol
1 Isobavachalcone
1 phytic acid, Inositol hexakisphosphate
1 Inositol
1 Ivermectin
1 Kaempferol
1 Licorice
1 Magnolol
1 Matrine
1 Methyl salicylate / Sweet Birch oil
1 Melatonin
1 Mushroom Chaga, Inonotus obliquus
1 Neem
1 Patchouli Oil (Pogostemon cablin)
1 Phenylbutyrate
1 Cisplatin
1 salinomycin
1 Shikonin
1 Aflavin-3,3′-digallate
1 triptolide
1 Urolithin
1 Vitamin C (Ascorbic Acid)
1 Zyflamend
1 γ-Tocotrienol
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:0  prod#:%  Target#:35  State#:%  Dir#:1
wNotes=0 sortOrder:rid,rpid

 

Home Page